← FDA DRUG APPROVALS

FDA ANDA · ANDA072538

BETAMETHASONE DIPROPIONATE

Sponsor: PADAGIS US

APPLICATION
ANDA072538
TYPE
ANDA
ORIGINAL APPROVAL
1990-01-31
LATEST ACTION
2013-01-28
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Prescription

Products

BETAMETHASONE DIPROPIONATEPrescription
BETAMETHASONE DIPROPIONATE EQ 0.05% BASE · LOTION · TOPICAL

Approval history

2013-01-28Labeling · Supplement 7AP
1997-12-16Labeling · Supplement 5AP
1997-01-24Labeling · Supplement 4AP
1995-05-05Manufacturing (CMC) · Supplement 3AP
1990-01-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →